A mammogram is a low-dose X-ray image of the breast, designed to detect cancer and other abnormalities before they can be felt by hand. The exam uses specialized equipment that compresses the breast between two plates, producing detailed images of the internal tissue. Most mammograms take about 20 minutes from start to finish, and the technology behind them has branched into several distinct types, each with different strengths depending on a person’s anatomy and risk profile.
How the Procedure Works
During a mammogram, you stand in front of a dedicated X-ray machine while a technologist positions one breast at a time on a flat support plate. A second plate presses down from above, compressing the breast firmly. This compression is the part most people remember, and it can be uncomfortable or briefly painful, but it serves a real purpose: flattening the tissue spreads it out so the X-rays can pass through more evenly, making small lesions easier to spot and reducing the radiation dose needed to get a clear picture.1Radiography. The application of breast compression in mammography: a new perspective Each breast is typically imaged from two angles, one from top to bottom and one from the side, producing a total of four images for a standard screening exam.
The entire imaging portion usually lasts only a few minutes per breast. The compression itself is held for just seconds at a time while the X-ray exposure is taken. You may be asked to hold your breath briefly to minimize any movement. Once the images are captured, a radiologist reviews them, sometimes that same day and sometimes within a few business days, depending on the facility.
Screening Versus Diagnostic Mammograms
There are two broad categories of mammogram, and the distinction matters for what you can expect. A screening mammogram is a routine check done on someone with no symptoms, aimed at catching cancer early. It follows a standard protocol of the four views mentioned above. A diagnostic mammogram, on the other hand, is ordered when something has already raised concern, whether a lump found on self-exam, a suspicious area on a previous screening, or unusual nipple discharge. Diagnostic mammograms involve additional images, often zoomed in on a specific region, and a radiologist is usually present to review the images in real time and request more if needed.
Specialist breast radiologists tend to outperform general radiologists in both settings. In one study, specialists detected about 6 cancers per 1,000 screening exams compared to roughly 3.4 per 1,000 for generalists, and had a lower recall rate, meaning fewer women were called back for additional workup that turned out to be nothing.2PubMed Central / Radiology. Performance parameters for screening and diagnostic mammography: specialist and general radiologists If you have access to a dedicated breast imaging center, the experience and accuracy can be meaningfully better than at a general radiology practice.
Types of Mammogram Technology
Standard two-dimensional digital mammography, often called 2D mammography, has been the workhorse of breast screening for decades. It produces flat images of the compressed breast, and radiologists look for masses, asymmetries, and tiny calcium deposits called microcalcifications that can signal early cancer. But 2D mammography has a well-known limitation: overlapping tissue can hide a real cancer or create the appearance of one that is not there.
3D Mammography (Tomosynthesis)
Three-dimensional mammography, or digital breast tomosynthesis, addresses the overlap problem by capturing a series of thin-slice images as the X-ray tube moves in an arc over the breast. The result is something like flipping through layers of breast tissue rather than looking at everything piled on top of itself. Multiple large studies have shown that adding 3D imaging to standard 2D improves cancer detection. In one population-based screening study, the combination detected about 8.1 cancers per 1,000 screens compared with 5.3 per 1,000 for 2D alone.3The Lancet Oncology. Integration of full-field digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study A large U.S. community practice study found a similar advantage: 3D imaging caught about 29% more cancers overall and 44% more invasive cancers, while also reducing false-alarm callbacks by about 16%.4PubMed. Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice
A follow-up study found that using a synthetic 2D image generated from the 3D data, rather than taking a separate 2D exposure, produced essentially the same detection rates while cutting the total radiation dose since you avoid the extra 2D exposure.5The Lancet Oncology. Breast cancer detection with 3-dimensional digital mammography (tomosynthesis) in population-based screening (STORM-2) The trade-off is that false-positive recall rates were slightly higher with 3D in that study, so the technology is not a pure win on every metric. Still, 3D mammography has become the default at many imaging centers.
Contrast-Enhanced Mammography
A newer option, contrast-enhanced mammography, borrows a principle from breast MRI. You receive an injection of iodine-based contrast dye before the exam, and the machine takes images at two different energy levels. Cancers tend to attract more blood flow than normal tissue, so the contrast pools in and around tumors, making them stand out on the high-energy images.6Radiographics. Contrast-enhanced Mammography: How Does It Work? This technique is still less widely available than standard or 3D mammography but is gaining traction for women at higher risk or those with dense breast tissue where standard imaging struggles.
How to Prepare
Most preparation is straightforward: avoid wearing deodorant, antiperspirant, powder, or lotion on your chest or underarms on the day of the exam. This is not a superstition. Metallic particles found in many antiperspirants and topical products can appear as bright white specks on the mammogram, mimicking the look of microcalcifications, which are one of the key things radiologists are looking for.7PubMed Central. Mammographic Breast Pseudocalcifications Associated With Topical Betamethasone Dipropionate Research has shown that solid-stick antiperspirants produce the most convincing mimic of real microcalcifications, while roll-on products are less likely to cause confusion.8PubMed. Effects of antiperspirant aluminum percent composition and mode of application on mock microcalcifications in mammography If you forget and apply something, the technologist may offer a wipe to clean the area before imaging.
If your breasts tend to be sore around your period, scheduling the mammogram for the week or two after your period ends may reduce discomfort during compression. Wearing a two-piece outfit makes the process easier since you only need to remove your top. And if you have had mammograms at a different facility in the past, bringing those images or having them transferred allows the radiologist to compare old and new, which dramatically helps in spotting subtle changes.
Understanding Your Results
Mammogram results are reported using a standardized system called BI-RADS, developed by the American College of Radiology. Rather than just telling you “normal” or “abnormal,” BI-RADS assigns a category from 0 to 6 that indicates how suspicious the findings are and what should happen next.9The Journal of the American Board of Family Medicine. BI-RADS Classification for Management of Abnormal Mammograms The system has been validated as a reliable predictor of actual cancer risk and helps standardize care across different radiologists and facilities.10PubMed. Positive predictive value of the Breast Imaging Reporting and Data System
Here is what the main categories mean in practice:
- BI-RADS 0: The images were incomplete or unclear, and you need additional imaging before the radiologist can make a call. This is common and not a reason to panic.
- BI-RADS 1: Negative. No suspicious findings at all.
- BI-RADS 2: Benign. The radiologist sees something, like a cyst or calcified fibroadenoma, but it is clearly not cancer.
- BI-RADS 3: Probably benign, with less than a 2% chance of malignancy. A short-interval follow-up mammogram in six months is typically recommended.
- BI-RADS 4: Suspicious. A biopsy is usually recommended. This category is subdivided into 4A, 4B, and 4C, reflecting increasing degrees of concern.
- BI-RADS 5: Highly suggestive of malignancy. Biopsy is strongly recommended.
- BI-RADS 6: Known cancer, confirmed by a previous biopsy. This category is used when imaging is done to monitor treatment response.
Getting called back after a screening does not mean you have cancer. A BI-RADS 0 result is the most common reason for a callback, and the additional imaging very often resolves the question without a biopsy.
Why Breast Density Matters
Your mammogram report will also include a breast density assessment, and this has become a major focus in breast screening over the past decade. Breasts are made up of fatty tissue and fibroglandular tissue in varying proportions. Dense breasts have more fibroglandular tissue relative to fat, and on a mammogram, both fibroglandular tissue and tumors appear white, which means dense tissue can hide a cancer that is sitting right behind it.
The research on this masking effect is striking. One study found that moving from lower to higher breast density within the normal range reduced the odds of detecting a cancer by about 61%.11Scientific Reports. Influence of mammographic density and compressed breast thickness on true mammographic sensitivity: a cohort study Another study quantified how this plays out in missed cancers: among women whose cancers were found between regular screenings (interval cancers, a sign that the previous mammogram missed something), roughly two-thirds had been classified as having high masking risk based on their breast density.12PubMed Central. Quantification of masking risk in screening mammography with volumetric breast density maps Density is also independently associated with a higher risk of developing breast cancer in the first place, though researchers continue to work out how much of the observed link reflects true biological risk versus the simple fact that dense breasts make cancers harder to find on a mammogram.13PubMed Central. Breast density and risk of breast cancer: masking and detection bias
If you are told you have dense breasts, it does not mean something is wrong. Roughly half of women over 40 have breasts classified as dense. But it does mean you and your doctor should discuss whether supplemental screening, such as ultrasound or MRI, would be worthwhile. A meta-analysis of supplemental screening options found that MRI added the most cancer detection above and beyond mammography, finding an extra 1.5 cancers per 1,000 screens that mammography alone had missed.14PubMed. Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis Other modalities like ultrasound and contrast-enhanced mammography showed no statistically significant difference from each other in that analysis.
Radiation, False Alarms, and Overdiagnosis
The radiation dose from a standard two-view digital mammogram is low, averaging about 3.7 milligray per exam.15PubMed. Radiation doses and cancer risks from breast imaging studies For context, that is roughly the amount of background radiation you absorb naturally over about seven weeks. The lifetime risk of a fatal radiation-induced breast cancer from a single mammogram at age 40 is estimated at about 1.3 per 100,000 women. A modeling study estimated that annual screening of 100,000 women from age 40 to 74 would cause about 125 radiation-induced breast cancers and 16 deaths, set against roughly 968 breast cancer deaths averted by the early detection that screening provides.16PubMed Central. Radiation-Induced Breast Cancer Incidence and Mortality from Digital Mammography Screening: A Modeling Study Switching to every-other-year screening starting at age 50 cut the radiation-related risk roughly fivefold in that same model.
The more common downside of screening is the false alarm. Among 1,000 U.S. women aged 50 who are screened annually for a decade, somewhere between 490 and 670 will experience at least one false-positive result that requires a callback, additional imaging, or biopsy that ultimately shows no cancer.17JAMA Internal Medicine. Quantifying the Benefits and Harms of Screening Mammography That same analysis estimated that 3 to 14 out of those 1,000 women would be overdiagnosed, meaning they would be treated for a cancer that never would have caused symptoms or shortened their life. Overdiagnosis remains one of the most debated aspects of mammography screening. The evidence clearly shows that screening reduces breast cancer deaths, but the balance between that benefit and the collective harms, including false positives and overdiagnosis, is tighter than many people assume.18PubMed Central. Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
When to Start and How Often
Screening guidelines have shifted in recent years. The U.S. Preventive Services Task Force now recommends that all women begin biennial (every two years) mammography screening at age 40 and continue through at least age 74. That starting age was lowered from 50 in the Task Force’s previous recommendation, driven by modeling data estimating that starting at 40 instead of 50 would avert an additional 1.3 breast cancer deaths per 1,000 women screened over a lifetime.19JAMA. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
The question of annual versus biennial screening is where guidelines get more nuanced. No randomized trial has directly compared the two schedules on survival outcomes. A large observational study using U.S. screening data found no statistically significant difference in the stage at which cancers were detected between women screened every year and those screened every two years, across all age groups.19JAMA. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement Collaborative modeling suggested biennial screening provides a more favorable balance of benefits to harms, since it roughly halves the number of false positives and the radiation exposure while preserving most of the mortality reduction. Some organizations, including the American Cancer Society, still recommend annual screening for women aged 45 to 54, so you may hear different advice depending on your doctor’s preferred guideline.
Mammograms With Breast Implants
If you have breast implants, you can and should still get mammograms, but the procedure requires a modified technique. Implants are radiopaque, meaning they block X-rays and can obscure the breast tissue behind them. The standard approach is called the Eklund maneuver, or implant displacement views: the technologist gently pushes the implant back against the chest wall and pulls the breast tissue forward over it, then compresses and images the tissue in front. A study of mammograms in women with implants found that these displacement views produced significantly better cancer visibility compared with standard positioning, though some trade-offs in overall positioning quality exist.20PubMed Central. Study of breast implants mammography examinations for identification of suitable image quality criteria The placement of the implant matters too: implants positioned under the chest muscle (subpectoral) allow more tissue to be pulled forward than those placed directly behind the breast tissue (subglandular).
If you have implants, let the scheduling staff know when booking so they can allot extra time and assign a technologist experienced with the technique. You should also mention the implants if you are going to a facility for the first time, since additional views will be needed and the radiologist interpreting the images needs that context.
Artificial Intelligence in Mammography
AI-assisted mammogram reading has moved out of the research phase and into real screening programs, with several large trials already published. The appeal is practical: in many European countries, every screening mammogram is read independently by two radiologists, which is effective but labor-intensive. AI offers a way to maintain or improve accuracy while reducing the human workload.
A large population-wide study tested three different ways to integrate AI into the double-reading workflow. The most promising approach used AI as a triage step: exams scored as low-risk by the algorithm were read by one radiologist instead of two, while higher-risk exams continued to get double reading with AI support. This setup slightly improved the cancer detection rate compared with standard double reading and actually reduced the number of cases sent to arbitration, all while cutting the total number of human reads by about 50%.21PubMed Central. AI-integrated Screening to Replace Double Reading of Mammograms: A Population-wide Accuracy and Feasibility Study A randomized trial in Sweden used a similar concept, with AI triaging exams and providing risk scores and computer-aided detection marks for radiologists to review on higher-risk cases.22The Lancet Oncology. Artificial intelligence-supported screening versus standard double reading for mammography: a randomised, controlled, population-based clinical trial
A more recent noninferiority trial confirmed the feasibility of a partially automated AI workflow in breast cancer screening, where cases classified as low risk were assessed as normal without full human reading, while the rest received standard double reading with AI assistance.23PubMed Central. AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial In countries that use single-reader screening, like the United States, AI is more likely to serve as a second set of eyes rather than a workload reducer. Either way, these tools are not replacing radiologists. They are reshaping how the reading workload is distributed and flagging cases that need closer attention.
Mammograms in Men
Breast cancer in men is rare, accounting for less than 1% of all breast cancer diagnoses, but it does occur. Men do not undergo routine screening mammography. However, if a man notices a lump, skin change, or nipple discharge, a mammogram may be ordered as part of the diagnostic workup. The imaging technique is the same in principle, though male breasts are smaller and the compression can feel awkward. A study examining imaging in men with benign breast lumps found complete agreement between what clinicians suspected before imaging and what the mammogram showed, suggesting that imaging is reliable in this population even though the anatomy differs.24PubMed Central. Is Breast Imaging in Male Patients With Benign Lumps Necessary? A Retrospective Study to Assess Concordance Between Clinical Diagnosis and Imaging Findings – Section: Results The most common finding in men is gynecomastia, a benign enlargement of breast tissue, which is easily distinguishable from cancer on imaging.